RXG

Pharmacy/Treatment Give

No description available in the specification.
33
C.LenElementv2.8.2
1-4=NMR1-00342RXG-1Give Sub-ID Counter
2-4=NMO1-00334RXG-2Dispense Sub-ID Counter
3---W1-00221RXG-3Quantity/Timing
4--CWER1029200317RXG-4Give Code
5--NMR1-00318RXG-5Give Amount - Minimum
6--NMO1-00319RXG-6Give Amount - Maximum
7--CWER1071500320RXG-7Give UnitsTable
8--CWEO1071600321RXG-8Give Dosage FormTable
9--CWEO*069100351RXG-9Administration NotesTable
101-IDO1016700322RXG-10Substitution Status
11---W1-01303RXG-11Dispense-to Location
121-IDO1013600307RXG-12Needs Human Review
131..250-CWEO*073800343RXG-13Special Administration InstructionsTable
14-20=STC1-00331RXG-14Give Per (Time Unit)
15-6=STO1-00332RXG-15Give Rate Amount
16--CWEO1072200333RXG-16Give Rate UnitsTable
17--NMO1-01126RXG-17Give Strength
18--CWEO1072301127RXG-18Give Strength UnitsTable
19-20=STO*-01129RXG-19Substance Lot Number
20--DTMO*-01130RXG-20Substance Expiration Date
21--CWEO*-01131RXG-21Substance Manufacturer Name
22--CWEO*069401123RXG-22IndicationTable
23-5#NMO1-01692RXG-23Give Drug Strength Volume
24--CWEO1074401693RXG-24Give Drug Strength Volume UnitsTable
25--CWEO1074501694RXG-25Give Barcode IdentifierTable
261-IDO1048001695RXG-26Pharmacy Order Type
27--CWEW1071401688RXG-27Dispense to Pharmacy2
28--XADW1-01689RXG-28Dispense to Pharmacy AddressOptionality
29--PLO1-01683RXG-29Deliver-to Patient Location
30--XADO1-01684RXG-30Deliver-to Address
31--EIO*-03393RXG-31Give Tag Identifier
32--NMC1-03316RXG-32Dispense Amount
33--CWEC1074603317RXG-33Dispense UnitsTable
3